| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/01/2004 | WO2004055189A1 New expression system from rhodococcus |
| 07/01/2004 | WO2004055188A1 Primer and probe for detecting vibrio cholerae or vibrio mimicus and detection method using the same |
| 07/01/2004 | WO2004055187A1 Recombinant viral-based malaria vaccines |
| 07/01/2004 | WO2004055186A1 Guanosine triphosphate-binding protein-coupled receptor |
| 07/01/2004 | WO2004055185A1 Novel protein and dna thereof |
| 07/01/2004 | WO2004055184A1 GLUCOSE AND/OR FRUCTOSE TRANSPORTER NaGLT1 AND ITS GENE |
| 07/01/2004 | WO2004055183A2 Carcinoembryonic antigen-specific immunodominant epitope recognized by cd4+t cells and uses thereof |
| 07/01/2004 | WO2004055182A1 In vivo affinity maturation scheme |
| 07/01/2004 | WO2004055181A1 Methods of treatment of feeding disorders or disorders of glucose uptake and for modifying metabolism and identifying therapeutic reagents therefor |
| 07/01/2004 | WO2004055178A1 Thermostable alpha-amylases |
| 07/01/2004 | WO2004055177A2 Artificial esterases |
| 07/01/2004 | WO2004055172A1 Bacterial strains delftia acidovorans mc1-s, production and use thereof for the production of the s enantiomers of 2-phenoxypropionic acid derivatives |
| 07/01/2004 | WO2004055167A2 Alphavirus particles and methods for preparation |
| 07/01/2004 | WO2004055166A2 Multi-antigenic alphavirus replicon particles and methods |
| 07/01/2004 | WO2004055162A2 Modulation of endothelial lipase expression |
| 07/01/2004 | WO2004055161A2 Large scale production of packaged alphavirus replicons |
| 07/01/2004 | WO2004055157A2 Methods of using vectors to treat metabolic disorders |
| 07/01/2004 | WO2004055153A2 Devices coated with substances that mediate the adhesion of biological material |
| 07/01/2004 | WO2004055056A1 Humanized antibody (h14.18) of the mouse 14.18 antibody binding to gd2 and its fusion with il-2 |
| 07/01/2004 | WO2004055051A1 Transcription control factor zhx3 |
| 07/01/2004 | WO2004055042A1 Biologically active peptide conjugates |
| 07/01/2004 | WO2004055035A1 A group of nucleic acid fragments for prevention of hiv infection or aids and the usage thereof |
| 07/01/2004 | WO2004054969A2 Sacromastigophoric therapeutic agent delivery system |
| 07/01/2004 | WO2004054907A2 Ftsz-polypeptides as a target for herbicidal compounds |
| 07/01/2004 | WO2004054614A1 Recombinant proteins of parapoxvirus ovis and pharmaceutical compositions therefrom |
| 07/01/2004 | WO2004054517A2 Compositions and methods for inhibiting tumor growth and metastasis |
| 07/01/2004 | WO2004054512A2 Therapeutic retroviral vectors for gene therapy |
| 07/01/2004 | WO2004054508A2 Immunogenic compositions including rough phenotype brucella host strains and complementation dna fragments |
| 07/01/2004 | WO2004054502A2 Modulation of tek expression |
| 07/01/2004 | WO2004054357A1 Methods and vectors for making knockout animals |
| 07/01/2004 | WO2004054351A2 Generation of plants with altered oil content |
| 07/01/2004 | WO2004054350A2 Generation of plants with altered oil content |
| 07/01/2004 | WO2004048519A3 Treatment of mammalian reaction to ige interactions |
| 07/01/2004 | WO2004041859A3 Peptide fragments of the harp factor inhibiting angiogenesis |
| 07/01/2004 | WO2004039985A3 Selective expression in filamentous fungi |
| 07/01/2004 | WO2004039944A3 Tri-block polymers for nanosphere-based drug or gene delivery |
| 07/01/2004 | WO2004029219A3 Cell-based rna interference and related methods and compositions |
| 07/01/2004 | WO2004029087A3 Bitter taste receptors |
| 07/01/2004 | WO2004027070A3 Transgenic expression cassettes for expressing nucleic acids in non-reproductive flower tissues of plants |
| 07/01/2004 | WO2004026240A3 Animal immunocontraceptives expressed in plants and uses thereof |
| 07/01/2004 | WO2004022780A3 Method for identifying substances having a herbicide action |
| 07/01/2004 | WO2004022701A3 Exponential amplification of nucleic acids using nicking agents |
| 07/01/2004 | WO2004020600A3 Modified aav |
| 07/01/2004 | WO2004018625A3 Ovarian cancer-specific promoter |
| 07/01/2004 | WO2004018512A3 Polymorphisms in the human genes for oct1 and their use in diagnostic and therapeutic applications |
| 07/01/2004 | WO2004017044A8 Chimeric protein |
| 07/01/2004 | WO2004015126A3 Antisense modulation of edg1 expression |
| 07/01/2004 | WO2004013168A3 Protein containing a burp domain |
| 07/01/2004 | WO2004013151A3 Campylobacter glycans and glycopeptides |
| 07/01/2004 | WO2004011638A3 Deoxyuridine 5' triphosphate nucleotidohydrolase polypeptides and structures |
| 07/01/2004 | WO2004011636A3 Method of enzymatic deubiquitination |
| 07/01/2004 | WO2004011601A3 Corn event pv-zmir13 (mon863) plants and compositions and methods for detection thereof |
| 07/01/2004 | WO2004011489A3 Tropism-modified adenoviral vectors, preferably for targeting b-lymphocytes or ovarian cells |
| 07/01/2004 | WO2004010956A3 Antisense modulation of lar expression |
| 07/01/2004 | WO2004010771A3 Nuclear transfer embryo formation method |
| 07/01/2004 | WO2004009789A3 Targeted adenoviral vector displaying immunoglobulin-binding domain and uses thereof |
| 07/01/2004 | WO2004009022A3 Method for augmenting vision in persons suffering from photoreceptor cell degeneration |
| 07/01/2004 | WO2004005513A3 Methods for specifically inhibiting histone deacetylase-7 and 8 |
| 07/01/2004 | WO2004005351A3 Neoplasm specific antibodies and uses thereof |
| 07/01/2004 | WO2004005315A3 Pin1 peptidyl-prolyl isomerase polypeptides, their crystal structures, and use thereof for drug design |
| 07/01/2004 | WO2004003511A3 Methods and compositions for the identification of antibiotics that are not susceptible to antibiotic resistance |
| 07/01/2004 | WO2004002216A3 Harvest-inducible genes from alfalfa (medicago sativa) and methods of use thereof |
| 07/01/2004 | WO2004001063A3 Methods and compositions for monitoring primer extension and polymorphism detection reactions |
| 07/01/2004 | WO2004001017A3 Methods for identifying antimicrobial agents, the agents identified therewith and methods of using same |
| 07/01/2004 | WO2004001001A3 Nucleic acid sequences and methods of use for the production of plants with modified polyunsaturated fatty acids |
| 07/01/2004 | WO2003106672A3 Method of utilizing the 5'end of transcribed nucleic acid regions for cloning and analysis |
| 07/01/2004 | WO2003106646A3 Antisense modulation of dual specific phosphatase 4 expression |
| 07/01/2004 | WO2003104451A3 Modifying the dna recombination potential in eukaryotes |
| 07/01/2004 | WO2003104416A3 Spliceosome mediated rna trans-splicing in stem cells |
| 07/01/2004 | WO2003103608A3 Neuroprotective synergy of erythropoietin and insulin-like growth factor |
| 07/01/2004 | WO2003100435A3 Diagnostics and therapeutic use of neuromedin u receptor 2 (nmu2) |
| 07/01/2004 | WO2003099996A3 Detection of secreted polypeptides |
| 07/01/2004 | WO2003099216A3 Fatty acid desaturases from fungi |
| 07/01/2004 | WO2003092716A3 Therapeutic use of pacap, maxadilan, pacap receptor agonist and/or adcyap1r1 in the treatment of cns disorders |
| 07/01/2004 | WO2003092582A3 Chimeric ebola virus envelopes and uses therefor |
| 07/01/2004 | WO2003091416A3 Constant length signatures for parallel sequencing of polynucleotides |
| 07/01/2004 | WO2003091386A3 A new family of picornaviruses |
| 07/01/2004 | WO2003083075A3 Retrovirus-based genomic screening |
| 07/01/2004 | WO2003080569A3 Egfr ligands and methods of use |
| 07/01/2004 | WO2003078600A3 Human monoclonal antibodies to influenza m2 protein and methods of making and using same |
| 07/01/2004 | WO2003068942A3 Identification of peptides that facilitate uptake and cytoplasmic and/or nuclear transport of proteins, dna and viruses |
| 07/01/2004 | WO2003057822A9 Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5' ends |
| 07/01/2004 | WO2003051278A3 Nanoparticle delivery vehicle |
| 07/01/2004 | WO2003048324A3 Antisense modulation of phospholipid scramblase 3 expression |
| 07/01/2004 | WO2003048202A3 Nf-kappab activating genes |
| 07/01/2004 | WO2003042240A3 Polypeptides of pseudomonas aeruginosa |
| 07/01/2004 | WO2003040366A3 Inhibitor oligonucleotides and their use for specific repression of a gene |
| 07/01/2004 | WO2003029429A9 Traversal of nucleic acid molecules through a fluid space and expression in repair cells |
| 07/01/2004 | WO2003024199A3 Production of transgenic avians using sperm-mediated transfection |
| 07/01/2004 | WO2003021265A8 Genetic construct intracellular monitoring system |
| 07/01/2004 | WO2003012045A3 Hybrid proteins with neuregulin heparin-binding domain for targeting to heparan sulfate proteoglycans |
| 07/01/2004 | WO2003009814A3 Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of prostate cancer |
| 07/01/2004 | WO2003000038A3 Compositions and methods for modulating plant development |
| 07/01/2004 | WO2002099083A3 Gfats as modifiers of the p53 pathway and methods of use |
| 07/01/2004 | WO2002083875A3 Transgenic mice containing channel activating protease 1 (cap1) gene disruptions |
| 07/01/2004 | WO2002077189A3 Glycosylation-resistant and nonglycosylated cyanovirins |
| 07/01/2004 | WO2002062834A3 Mixture of peptides originating from a nef protein and applications thereof |
| 07/01/2004 | WO2002015846A3 Anti-rank ligand monoclonal antibodies useful in treatment of rank ligand mediated disorders |
| 07/01/2004 | WO2002014463A8 Method for genetic transformation of woody trees |
| 07/01/2004 | US20040128721 Cell cycle stress-related proteins and methods of use in plants |